Concepedia

A.J. de Langen

AD

2

Publications

49

Citations

2

H-Index

2022

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The Netherlands Cancer Institute

A.J. de Langen is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, lung cancer, and tumor biology.

Top concepts

MedicineOncologyPathologyLung CancerTumor BiologyCancer TherapyCancer GeneticsMolecular OncologyCancer Cell Biology

Publications per year

2022–2024

2

Publications

2

LBA10 Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study

M.L. Johnson, A.J. de Langen, D.M. Waterhouse et al. · Annals of Oncology · 2022 · 39 citations · Full text

Medicine, Pathology, Cancer Cell Biology +9

PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations

X. Le, Y. Zhao, D. Planchard et al. · Journal of Thoracic Oncology · 2024 · 10 citations · Full text

Rows per page

1–2 of 2